IMTXW NASDAQ
immatics biotechnologies GmbH
1W: -92.1%
1M: -96.4%
3M: -98.8%
1Y: -100.0%
3Y: -100.0%
$0.00
Last traded 2025-06-30 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$170M
-7.4% ▼
Capital Expenditures
$6M
+61.8% ▲
5Y CAGR: -3.5%
Free Cash Flow
-$176M
-0.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$137M
+650.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$93M | $38M | -$95M | $15M | -$189M |
| Depreciation & Amort. | $5M | $7M | $7M | $12M | $12M |
| Stock-Based Comp. | $26M | $23M | $21M | $18M | $0 |
| Change in Working Capital | -$32M | $37M | $82M | -$164M | -$42M |
| Other Non-Cash Items | $433K | -$9M | $3M | -$45M | $49M |
| Operating Cash Flow | -$82M | $100M | $18M | -$158M | -$170M |
| — Investing Activities — | |||||
| Capital Expenditures | -$6M | -$6M | -$31M | -$16M | -$7M |
| Acquisitions (Net) | $551K | -$200M | $0 | $0 | $0 |
| Investment Purchases | -$11M | -$216M | -$415M | -$450M | -$325M |
| Investment Sales | $24M | $13M | $415M | $314M | $528M |
| Other Investing | -$551K | $200M | -$8K | -$206K | $0 |
| Investing Cash Flow | $7M | -$210M | -$31M | -$152M | $197M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | -$3M | -$4M | -$2M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | -$8M | -$2M | -$21M | -$3M |
| Financing Cash Flow | -$3M | $124M | $85M | $320M | $94M |
| Net Change in Cash | -$75M | $16M | $70M | $18M | $137M |
| Cash End of Period | $133M | $149M | $218M | $237M | $346M |
| Free Cash Flow | -$87M | $94M | -$13M | -$175M | -$176M |